Drotaverine
Not to be confused with doravirine.
Systematic (IUPAC) name | |
---|---|
(Z)-1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline | |
Clinical data | |
Trade names | No-Spa |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, intravenous, intramuscular |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Highly variable (~65%), peak at 45–60 min |
Protein binding | 95–98% |
Metabolism | Hepatic |
Biological half-life | 7–16 hours |
Excretion | >50% in urine and ~30% in bile[1] |
Identifiers | |
CAS Number | 985-12-6 |
ATC code | A03AD02 (WHO) |
PubChem | CID 1712095 |
DrugBank | DB06751 |
ChemSpider | 1361582 |
UNII | 98QS4N58TW |
KEGG | D07879 |
ChEMBL | CHEMBL551978 |
Chemical data | |
Formula | C24H31NO4 |
Molar mass | 397.507 g/mol |
| |
| |
(verify) |
Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, used to enhance cervical dilation during childbirth.[2]:283
It is structurally related to papaverine, is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects.[3]
It is available in Asian and Eastern European countries under several brand names, with No-Spa being one of them.[4][5]
See also
References
- 1 2 "Инструкция по применению препарата Но-шпа® // No-Spa® (tablets) Full Prescribing Information". National Register of Drugs (in Russian). Chinoin Pharmaceutical and Chemical Works. pp. 3–8.
- ↑ Padubidri V and Anand E. Title Textbook of Obstetrics. BI Publications Pvt Ltd, 2006 ISBN 9788172252236
- ↑ "The DrugBank database: Drotaverine". DrugBank Version 4.1. The Metabolomics Innovation Centre. Retrieved 9 August 2014.
- ↑ Drotaverine - Drugs.com Drugs.com international listings for drotaverine Page accessed June 28, 2015
- ↑ No-Spa - Drugs.com No-Spa contents
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.